Patents Assigned to The University
-
Patent number: 9625588Abstract: Large-area, flat-panel photo-detectors with sub-nanosecond time resolution based on microchannel plates are provided. The large-area, flat-panel photo-detectors enable the economic construction of sampling calorimeters with, for example, enhanced capability to measure local energy deposition, depth-of-interaction, time-of-flight, and/or directionality of showers. In certain embodiments, sub-nanosecond timing resolution supplies correlated position and time measurements over large areas. The use of thin flat-panel viewing radiators on both sides of a radiation-creating medium allows simultaneous measurement of Cherenkov and scintillation radiation in each layer of the calorimeter. The detectors may be used in a variety of applications including, for example, medical imaging, security, and particle and nuclear physics.Type: GrantFiled: December 29, 2015Date of Patent: April 18, 2017Assignees: The University of Chicago, Minotech Engineering, Inc.Inventors: Henry Frisch, Fukun Tang, Herve Grabas, Eric J. Oberla, Michael Minot
-
Patent number: 9625469Abstract: The present invention relates to methods for identifying amino acids in peptides. In one embodiment, the present invention contemplates labeling the N-terminal amino acid with a first label and labeling an internal amino acid with a second label. In some embodiments, the labels are fluorescent labels. In other embodiments, the internal amino acid is lysine. In other embodiments, amino acids in peptides are identified based on the fluorescent signature for each peptide at the single molecule level.Type: GrantFiled: June 22, 2012Date of Patent: April 18, 2017Assignee: Board Of Regents, The University of Texas SystemInventors: Edward Marcotte, Jagannath Swaminathan, Andrew Ellington, Eric Anslyn
-
Patent number: 9625450Abstract: A method of obtaining a mixture of cells enriched in hepatic progenitors is developed which comprises methods yielding suspensions of a mixture of cell types, and selecting those cells that are classical MHC class I antigen(s) negative and ICAM-1 antigen positive. The weak or dull expression of nonclassical MHC class I antigen(s) can be used for further enrichment of hepatic progenitors. Furthermore, the progenitors can be selected to have a level of side scatter, a measure of granularity or cytoplasmic droplets, that is higher than that in non-parenchymal cells, such as hemopoietic cells, and lower than that in mature parenchymal cells, such as hepatocytes. Furthermore, the progeny of the isolated progenitors can express alpha-fetoprotein and/or albumin and/or CK19. The hepatic progenitors, so isolated, can grow clonally, that is an entire population of progeny can be derived from one cell. The clones of progenitors have a growth pattern in culture of piled-up aggregates or clusters.Type: GrantFiled: April 3, 2014Date of Patent: April 18, 2017Assignee: The University of North Carolina at Chapel HillInventors: Hiroshi Kubota, Lola M. Reid
-
Static random access memory cell having improved write margin for use in ultra-low power application
Patent number: 9627042Abstract: A static random access memory (SRAM) cell is provided with improved write margin. The SRAM cell includes: a pair of inverters cross coupled to each other and forming two storage nodes; read access switches electrically coupled between a read bit line and the two storage nodes; write access switches electrically coupled between write bit lines and two storage nodes; and supply switches electrically coupled between a supply voltage and the pair of inverters and operable, in response to a signal on at least one of the write bit lines, to selectively connect the supply voltage to at least one of the inverters in the pair of inverters. During a write operation, the supply switches operate to cut off the supply voltage to the inverter in the pair of inverters having a charged state.Type: GrantFiled: December 30, 2013Date of Patent: April 18, 2017Assignee: The Regents Of The University of MichiganInventors: Pinaki Mazumder, Jaeyoung Kim, Nan Zheng -
Patent number: 9622662Abstract: A hyperspectral imaging system having an optical path. The system including an illumination source adapted to output a light beam, the light beam illuminating a target, a dispersing element arranged in the optical path and adapted to separate the light beam into a plurality of wavelengths, a digital micromirror array adapted to tune the plurality of wavelengths into a spectrum, an optical device having a detector and adapted to collect the spectrum reflected from the target and arranged in the optical path and a processor operatively connected to and adapted to control at least one of: the illumination source; the dispersing element; the digital micromirror array; the optical device; and, the detector, the processor further adapted to output a hyperspectral image of the target.Type: GrantFiled: February 25, 2013Date of Patent: April 18, 2017Assignee: Board of Regents, The University of Texas SystemInventors: Karel J. Zuzak, Jeffrey A. Cadeddu, Rafael Ufret-Vincenty, Robert P. Francis, Edward Livingston
-
Patent number: 9624211Abstract: Provided are methods and compositions for the treatment of diseases such as cancer. In certain aspects, compounds which can inhibit Skp2 are provided. Specifically chromenone derivatives are disclosed that have the capability toward reducing differentiation of pluripotent, multipotent or totipotent cells and thus have therapeutic utility in the treatment of a proliferative disease such as cancer.Type: GrantFiled: July 18, 2014Date of Patent: April 18, 2017Assignee: Board of Regents, The University of Texas SystemInventors: Shuxing Zhang, Hui-Kuan Lin, Chia-Hsin Chan, John Kenneth Morrow
-
Patent number: 9624548Abstract: Described are bladder cancer specific biomarkers and lung cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of bladder cancer and lung cancer.Type: GrantFiled: December 21, 2009Date of Patent: April 18, 2017Assignee: The University of SurreyInventors: Richard Morgan, Hardev Pandha
-
Application architecture design method, application architecture design system, and recording medium
Patent number: 9626156Abstract: Provided is an application architecture design method in which an information processing device is used, the method including the steps of: inputting information about dependency relations and design aspects, which are design items regarding modules for running functions, virtual machines for running the modules, and physical machines for running the virtual machines; and executing processing of adapting architecture properly by switching the input information about the dependency relations and the design aspects in matrices in a DSM format, and thereby rearranging allocation of the modules, allocation of the virtual machines, and allocation of the physical machines in stages in the DSM format. As a result, an excellent design solution for architecture suitable for a virtualized environment, a cloud environment deriving, or a similar environment can be derived.Type: GrantFiled: April 19, 2012Date of Patent: April 18, 2017Assignees: NEC Corporation, Tokyo Metropolitan University, The University of TokyoInventors: Shigeru Hosono, Koji Kimita, Fumiya Akasaka, Tatsunori Hara, Yoshiki Shimomura, Tamio Arai -
Publication number: 20170100586Abstract: Provided is an electrical stimulation device including a first to fourth electrodes, and an electrical stimulation generation section which supplies an electrical stimulation signal to each of the first to fourth electrodes. The electrical stimulation generation section supplies, to the first and second electrodes, an electrical stimulation signal according to a first stimulation pattern, and supplies, to the third and fourth electrodes, an electrical stimulation signal according to a second stimulation pattern. The first stimulation pattern is set so that an electrical stimulation signal for changing stimulation intensity according to a first waveform is supplied to the first electrode, and an electrical stimulation signal for changing stimulation intensity according to a second waveform is supplied to the second electrode, the second waveform being increased and decreased in conjunction with the first waveform.Type: ApplicationFiled: July 23, 2014Publication date: April 13, 2017Applicants: SYSTEM INSTRUMENTS CO., LTD., The University of Electro-CommunicationsInventors: Takeshi AKIBA, Hiroshi YOKOI
-
Publication number: 20170099838Abstract: Formulations having, as active agents, at least one quaternized polymeric microgel and at least one nonionic surfactant, methods of making, and methods of using are described.Type: ApplicationFiled: December 19, 2016Publication date: April 13, 2017Applicant: The University of ToledoInventors: Yakov Lapitsky, Youngwoo Seo, Kristopher Richardson
-
Publication number: 20170101613Abstract: Methods and systems for the isomerization and fermentation of xylose and hexose sugars using an immobilized enzyme system capable of sustaining two different pH microenvironments in a single vessel are disclosed. Bilayer particles are dispersed in a mixture comprising an ionic borate source and xylose. The bilayer particles have a first region with a first enzymatic activity comprising xylose isomerase and a pH of 6 or above, and a second region having a second enzymatic activity at an acidic pH.Type: ApplicationFiled: December 22, 2016Publication date: April 13, 2017Applicant: The University of ToledoInventors: Sasidhar Varanasi, Kripa Rao, Patricia Ann Relue, Dawei Yuan
-
Patent number: 9617589Abstract: A microfluidic device includes a plurality of reaction wells; and a plurality of solid supports, and each of the solid supports has a reagent attached thereto. The reagent is attached to the solid support via a labile reagent/support bond such that the reagent is configured to be cleaved from the support via a cleaving operation.Type: GrantFiled: March 15, 2013Date of Patent: April 11, 2017Assignee: The University of North Carolina at Chapel HillInventors: John Michael Ramsey, William Henley, Emily Oblath
-
Patent number: 9616540Abstract: Devices, systems, and methods are provided for controlling a quantity of cutting fluid dispensed for a cutting tool within a CNC or other machining system. The devices, systems, and methods may include controlling multiple fluids such that coolant, lubricant, or other fluids can be delivered at different locations, at different flow rates, have their flow rates changed independently, and/or have their flow rates changed dynamically during a machining operation. In some embodiments, a feedback loop or input may be provided to obtain and/or provide information regarding the machining operation—such as cutting force, cutting temperature, cutting friction, machining operation, tool in use, work piece geometry, and/or material—and automatically and/or independently modify the fluid flow rates. The fluid may be atomized with air or other gases to minimize the quantities of fluid used. Components in the system may be modular to allow the system to be used with existing and new machining technologies.Type: GrantFiled: February 8, 2012Date of Patent: April 11, 2017Assignee: The University of Utah Research FoundationInventors: Alagar Krishnan Balaji, Venugopal Raghavendra Ghatikar
-
Patent number: 9616048Abstract: This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.Type: GrantFiled: October 19, 2015Date of Patent: April 11, 2017Assignee: Board of Regents of The University of Texas SystemInventors: Steven L. McKnight, Andew A. Pieper, Joseph M. Ready, Jef K. De Brabander, Jeffrey M. Zigman
-
Patent number: 9620351Abstract: Mass spectrometry systems or assemblies therefore include an ionizer that includes at least one planar conductor, a mass analyzer with a planar electrode assembly, and a detector comprising at least one planar conductor. The ionizer, the mass analyzer and the detector are attached together in a compact stack assembly. The stack assembly has a perimeter that bounds an area that is between about 0.01 mm2 to about 25 cm2 and the stack assembly has a thickness that is between about 0.1 mm to about 25 mm.Type: GrantFiled: May 20, 2016Date of Patent: April 11, 2017Assignee: The University of North Carolina at Chapel HillInventor: John Michael Ramsey
-
Patent number: 9615735Abstract: Systems and methods for determining thickness of lipid and aqueous layers of a tear film in which a spectrum array is generated from optical coherence tomography and input into a statistical estimator, which determines the thickness of the lipid and/or aqueous layers at a nanometer resolution based on the inputted spectrum and other information, such as information about a laser intensity noise, Poisson noise, and dark noise associated with the OCT.Type: GrantFiled: November 19, 2014Date of Patent: April 11, 2017Assignees: University of Rochester, The Arizona Board of Regents on Behalf of The University of ArizonaInventors: Jinxin Huang, Jannick P. Rolland, Eric Clarkson, Matthew Kupinski
-
Patent number: 9616062Abstract: The presently disclosed subject matter relates to methods and compositions for protecting healthy cells from damage due to DNA damaging agents. In particular, the presently disclosed subject matter relates to the protective action of selective cyclin dependent kinase 4/6 (CDK4/6) inhibitors administered to subjects that have been exposed to or that are at risk of exposure to DNA damage.Type: GrantFiled: December 11, 2013Date of Patent: April 11, 2017Assignee: The University of North Carolina at Chapel HillInventors: Norman E. Sharpless, Patrick J. Roberts, Kwok-Kin Wong, Soren Johnson
-
Patent number: 9618521Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.Type: GrantFiled: April 10, 2014Date of Patent: April 11, 2017Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas SystemInventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
-
Patent number: 9618479Abstract: Devices and methods generate an ordered restriction map of genomic DNA extracted from whole cells. The devices have a fluidic microchannel that merges into a reaction nanochannel that merges into a detection nanochannel at an interface where the nanochannel diameter decreases in size by between 50% to 99%. Intact molecules of DNA are transported to the reaction nanochannel and then fragmented in the reaction nanochannel using restriction endonuclease enzymes. The reaction nanochannel is sized and configured so that the fragments stay in an original order until they are injected into the detection nanochannel. Signal at one or more locations along the detection nanochannel is detected to map fragments in the order they occur along a long DNA molecule.Type: GrantFiled: October 29, 2015Date of Patent: April 11, 2017Assignee: The University of North Carolina at Chapel HillInventors: John Michael Ramsey, Laurent Menard
-
Patent number: 9617239Abstract: This invention relates generally to compounds that are glucuronidase inhibitors. Glucuronidase inhibitors described include phenoxy thiophene sulfonamides. Other compounds, for instance pyridine sulfonyls, benzene sulfonyls, thiophene sulfonyls, thiazole sulfonyls, thiophene carbonyls, and thiazole carbonyls, are also contemplated. Also contemplated are compositions including one or more of such compounds for use inhibiting glucuronidase and methods of using one or more of such compounds as a co-drug to be used in combination with the anticancer drug CPT-11.Type: GrantFiled: March 10, 2011Date of Patent: April 11, 2017Assignees: North Carolina Central University, The University of North Carolina at Chapel HillInventors: Alfred L. Williams, John Scott, Li-An Yeh, Matthew Robert Redinbo